A successful purchase, pegged for about $45 billion, would be the latest deal in health care, a spree that has ranged from drug makers to insurance providers.
Teva Said to Be Close to Buying Generic Drug Unit of Allergan
The New York Times - 26 Jul 2015 03:57
A successful purchase, pegged for about $45 billion, would be the latest deal in health care, a spree that has ranged from drug makers to insurance providers.
Share this Article
Comment on this Article
Recommended
Please to comment